Modalis Therapeutics (4883.TSE) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-14
-11
-8
-6

Details

Expected EPS
N/A
Actual EPS
-6
Surprise EPS
-6
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -6 per share for Q4 2024.

0 Comments

Share your thoughts